Functional imaging for assessment of therapy

British Journal of Radiology

Volumn 75, Issue SPEC. ISS., 2002, Pages

  Schwaigner, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA V BETA3 INTEGRIN; ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE; GALLIUM 67; INTEGRIN; UNCLASSIFIED DRUG;

BED; BIOMEDICAL ENGINEERING; CANCER; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONFERENCE PAPER; DRUG UPTAKE; ESOPHAGUS CANCER; FUNCTIONAL ANATOMY; HUMAN; IMAGING SYSTEM; LABORATORY; LYMPHOMA; MEDICAL INSTRUMENTATION; MEDICAL RESEARCH; METHODOLOGY; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; MOLECULAR PROBE; POSITRON EMISSION TOMOGRAPHY; RADIOIMMUNOTHERAPY; RESIDUE ANALYSIS; TRANSPORT KINETICS; TREATMENT OUTCOME; TUMOR;

EID: 0036452451     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.75.suppl_9.750067     Document Type: Conference Paper

References (26)

1. Cook GJR. The clinical use of PET - Where are we now? Br J Radiol 2001; 74:399-401.
2. Hillman BJ, Neiman HL. Translating molecular imaging research into radiologic practice: Summary of the proceedings of the American College of Radiology Colloquium, April 22-24, 2001. Radiology 2002; 222:19-24.
3. Schwaiger M, Wester HJ. Molecular imaging: Dream or reality? Nuklearmedizin (In German)
4. Gambhir SS, Herschman HR, Cherry SR, Barrio JR, Satyamurthy N, Toyokuni T, Phelps ME, Larson SM, Balatoni J, Finn R, Sadelain M, Tjuvajev J, Blasberg R. Imaging transgene expression with radionuclide imaging technologies. Neoplasia 2002;2:118-38.
5. Bremer C, Bredow S, Mahmood U, Weissleder R, Tung CH. Optical imaging of matrix metallo-proteinase-2 activity in tumors: Feasibility study in a mouse model. Radiology 2001;221:523-9.
6. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med 2001;42:1S-93S.
7. Reske SN, Kotzerke J. FDG-PET for clinical use. Results of the 3rd German interdisciplinary consensus conferen, 'Onko PET III', 21 July and 19 September 2000. Eur J Nucl Med 2001;28:1707-23.
8. Van Der Hiel B, Pauwels EK. Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology: Therapy response monitoring in breast cancer, lymphoma and gliomas. Cancer Res Clin Onco 2001;127:269-77.
9. Prauer HW, Weber WA, Romer W, Treumann T, Ziegler SI, Schwaiger M. Controlled prospective study of positron emission tomography using the glucose analogue [18f] fluorodeoxyglucose in the evaluation of pulmonary nodules. Br J Surg 1998;85:506-11.
10. Kostakoglu L, Goldsmith SJ. Positron emission tomography in lymphoma: Comparison with computed tomography and gallium-67 single photon emission computed tomography. Clin Lymphoma 2000;1:67-74.
11. Spaepen K, Stroobants S, Dupont P, Van Steenweghen S, Thomas J, Vandenberghe P, Vanuytsel L, Vormans G, Balzarini J, De Wolf-Peeters C, Mortelmans L, Verhoef G. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after firstline chemotherapy in non-Hodgkin's lymphoma; Is [18F] FDG-PET a valid alternative to conventional diagnostic methods? J Clin Oncol 2001;19:414-9.
12. Jerusalem G, Beguin Y, Fassotte MF, Najjar F, Paulus P, Rigo P, Fillet G. Whole-body positron emission tomography using 18F-fluorodeoxy-glucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classicla computed tomography scanning. Blood 1999;94:429-33.
13. Mikhaeel NG, Timothy AR, O'Doherty MJ, Hain S, Maisey MN. 18-FDG-PET as a prognostic indicator in the treatment of aggressive non-Hodgkin's lymphoma - Comparison with CT. Leuk Lymphoma 2000;39:543-53.
14. Weber WA, Ziegler SI, Thodtmann R, Hanauske AR, Schwaiger M. Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med 1999;40:1771-7.
15. Brady F, Luthra SK, Brown GD, Osman S, Aboagye E, Saleem A, Price PM. Radiolabelled tracers and anticancer drugs for assessment of therapeutic efficacy using PET. Curr Pharm Des 2001;7:1863-92.
16. Haberkorn U, Morr IOF, Bellemann ME, Blatter J, Altmann A, Kahn B, Van Kaick G. Fluorodeoxyglucose uptake in vitro: Aspects of method and effects of treatment with gemcitabine. J Nucl Med 1994;35:1842-50.
17. Brucher BL, Weber W, Bauer M, Fink U, Avril N, Stein HJ, Werner M, Zimmermann F, Siewert JR, Schwaiger M. Neoadjuvant therapy of esophageal squamous cell carcinome: Response evaluation by positron emission tomography. Ann Surg 233:320-1.
18. Romer W, Hanauske AR, Ziegler S, Thodtmann R, Weber W, Fuchs C, Enne W, Herz M, Nerl C, Garbrecht M, Schwaiger M. Positron emission tomography in non-Hodgkin's lymphoma: Assessment of chemotherapy with fluorodeoxyglucose. Blood 1998;91:4464-71.
19. Weber WA, Ott K, Becker K, Dittler HJ, Helmberger H, Avril NE, Meisetschlager G, Busch R, Siewert JR, Schwaiger M, Fink U. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 2001;19:3058-65.
20. Boerman OC, Oyen WJ, Corstens FH. Radiolabeled receptor-binding peptides: A new class of radiopharmaceuticals. Semin Nucl Med 2000;30:195-208.
21. Stocklin G, Wester HJ. In: Gulyás B, Müller-Gärtner HW (editors). Strategies for Radioligand Development: Peptides for Tumor Targeting. The Netherlands: Kluwer Academic Publishers. 1998:57-90.
22. Okarvi SM. Recent progress in fluorine-18 labelled peptide radiopharmaceuticasl. Eur J Nucl Med 2001;28:929-38.
23. Schumacher J, Kaul S, Klivenyi G, Junkermann H, Magener A, Henze M, Doll J, Haberkorn U, Amelung F, Bastert G. Immunoscintigraphy with positron emission tomography: Gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies. Cancer Res 2001;61:3712-7.
24. Haubner R, Wester HJ, Weber WA, Mang C, Ziegler SI, Goodman SL, Senekowitsch-Schmidtke R,Kessler H, Schwaiger M. Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labelled RGD-containing glycopeptide and positron emission tomography. Cancer Res 2001;61:1781-5.
25. Tjuvajev JG, Chen SH, Joshi A, Joshi R, Guo ZS, Balatoni J, Ballon D, Koutcher J, Finn R, Woo SL, Blasberg RG. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res 1999;59:5186-93.
26. Jacobs A, Voges J, Reszka R, Lercher M, Gossmann A, Kracht L, Kracht L, Kaestle C, Wagner R, Wienhard K, Heiss WD. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 2001;358:727-9.